NUVATION BIO INC ($NUVB)

2 tracked superinvestors hold NUVATION BIO INC (NUVB), worth $20M combined, led by Stanley Druckenmiller. Smart money is accumulating NUVB as of the latest 13F filings.

Current price

$6.11

BiotechnologyNYSEUS

+151.5%

1Y

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor…

Market cap

$1.6B

P/E

-7.48

Div yield

0.0%

Revenue YoY

699.0%

Analyst target

$16

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

2

tracked 13F / N-PORT funds

Combined value

$20M

disclosed long exposure

Tier-1 conviction

2

concentrated holders

Net this quarter

+1

1 buying · 0 selling

Smart money is net accumulating NUVB: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.

The smart-money take on NUVB

NUVATION BIO INC (NUVB) is held by 2 tracked funds worth $20M combined, 2 of them concentrated Tier-1 managers whose positions carry real conviction.

The largest position belongs to Stanley Druckenmiller at 0.6% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

This quarter 1 fund opened a brand-new position (Stanley Druckenmiller), with 0 adding and 0 trimming — a net accumulation signal.

Superinvestors holding NUVB

InvestorMove% of their portfolioPosition value
1
Stanley Druckenmiller

Duquesne Family Office

New buy0.6%$19M
1
David Einhorn

Greenlight Capital

Held0%$150K

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own NUVB?

2 tracked funds hold NUVATION BIO INC (NUVB), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.6% of its 13F portfolio. 2 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling NUVB?

In the most recent 13F quarter, 1 tracked fund added or opened NUVB and 0 trimmed it, including 1 brand-new position.

How much NUVB do tracked funds hold?

Combined disclosed long exposure to NUVB across tracked superinvestors is $20M as of the Mar 2026 filings.

Stocks often held alongside NUVB

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.